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Trypanosoma cruzi is the obligate intracellular parasite that causes Chagas disease. The
pathogenesis of this disease is a multifactorial complex process that involves a large num-
ber of molecules and particles, including the extracellular vesicles. The presence of EVs of
T. cruzi was first described in 1979 and, since then, research regarding these particles has
been increasing. Some of the functions described for these EVs include the increase in
heart parasitism and the immunomodulation and evasion of the host immune response.
Also, EVs may be involved in parasite adhesion to host cells and host cell invasion.
Methodology/Principal findings
EVs (exosomes) of the Pan4 strain of T. cruzi were isolated by differential centrifugation,
and measured and quantified by TEM, NTA and DLS. The effect of EVs in increasing the
parasitization of Vero cells was evaluated and the ED50 was calculated. Changes in cell
permeability induced by EVs were evaluated in Vero and HL-1 cardiomyocyte cells using
cell viability techniques such as trypan blue and MTT assays, and by confocal microscopy.
The intracellular mobilization of Ca2+ and the disruption of the actin cytoskeleton induced
by EVs over Vero cells were followed-up in time using confocal microscopy. To evaluate
the effect of EVs over the cell cycle, cell cycle analyses using flow cytometry and Western
blotting of the phosphorylated and non-phosphorylated protein of Retinoblastoma were
performed.
Conclusion/Significance
The incubation of cells with EVs of trypomastigotes of the Pan4 strain of T. cruzi induce a
number of changes in the host cells that include a change in cell permeability and higher
intracellular levels of Ca2+ that can alter the dynamics of the actin cytoskeleton and arrest







Citation: Retana Moreira L, Rodrı́guez Serrano F,
Osuna A (2019) Extracellular vesicles of
Trypanosoma cruzi tissue-culture cell-derived
trypomastigotes: Induction of physiological
changes in non-parasitized culture cells. PLoS Negl
Trop Dis 13(2): e0007163. https://doi.org/10.1371/
journal.pntd.0007163
Editor: Igor C. Almeida, University of Texas at El
Paso, UNITED STATES
Received: August 16, 2018
Accepted: January 16, 2019
Published: February 21, 2019
Copyright: © 2019 Retana Moreira et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: Lissette Retana Moreira was supported
by the “Oficina de Asuntos Internacionales y
Cooperación Externa (OAICE)” of the University of
Costa Rica and the “Ministerio de Ciencia,
Tecnologı́a y Telecomunicaciones (MICITT)” and
“Consejo Nacional para Investigaciones Cientı́ficas
y Tecnológicas” (CONICIT)” of the Government of
the cell cycle at G0/G1 prior to the DNA synthesis necessary to complete mitosis. These
changes aid the invasion of host cells and augment the percentage of cell parasitization.
Author summary
Extracellular vesicles (EVs) are a diverse group of nanoparticles involved in intercellular
communication under physiological and pathological conditions. Trypanosoma cruzi, the
protozoan that causes Chagas disease, releases EVs that facilitate parasite invasion of the
host cell, immunomodulate the host response, and help the parasite to evade this response.
However, little is known about how the host cell is altered. In this work, we confirm that
EVs of tissue-culture cell-derived trypomastigotes of the Pan4 strain increase cell parasit-
ism. We also demonstrate that EVs affect cell permeability in Vero cells and cardiomyo-
cytes and raise intracellular Ca2+ levels, altering the actin filaments and arresting the cell
cycle at the G0/G1 phases. This work seeks to elucidate the way in which EVs influence
certain aspects of the cell physiology that favour the establishment of this parasite inside
the host cell.
Introduction
Trypanosoma cruzi is an intracellular protozoan parasite that causes Chagas disease or Ameri-
can trypanosomiasis. An estimated 8 million people are infected with this parasite worldwide,
with some 300,000 new cases and 15,000 deaths annually [1]. T. cruzi has a life cycle that
includes mammals and blood-sucking bugs (Hemiptera, Reduviidae) as hosts. Humans can be
infected through the insects faeces, by vertical (congenital) transmission, transmission by
blood transfusions, organ transplants, or oral contamination via tainted fluids and foods [2].
Chagas disease displays symptomatic and pathological variations among infected individu-
als [3] but is characterized by an acute as well as a chronic stage. During the chronic stage,
approximately 30% of the patients develop significant complications, which may include
megasyndromes of the gastrointestinal tract (such as megacolon or megaesophagus), neuro-
logical complications, and cardiomyopathy [4–7].
The pathogenesis of Chagas disease is a multifactorial process. The molecular invasion
mechanisms by T. cruzi trypomastigotes (T) and the associated regulatory pathways have been
intensely investigated for many years [8]. A large number of molecules have been involved and
are described as part of the secretome of T. cruzi [9]. Some of them are included in extracellu-
lar vesicles (EVs). EVs are small membrane-bound vesicles classified based on their size, bio-
genesis, and composition [10] in: a) exosome-like EVs (20–100 nm), b) ectosome-like EVs
(100–1000 nm) and c) apoptotic blebs (>1000 nm) [9,11].
The presence of EVs of T. cruzi was first described in 1979 by da Silveira et al., who demon-
strated the secretion of plasma-membrane vesicles by T. cruzi epimastigote forms [12]. These
vesicles were later detected by Gonçalves et al. (1991) in host-cell-derived trypomastigotes
[13]. Since then, numerous publications concerning EVs have appeared, demonstrating their
role in cell-to-cell communication, pathogenesis, evasion of the immune response and
diagnosis.
The cargo of EVs of T. cruzi contain proteins involved in host-parasite interactions, signal-
ling, trafficking, and membrane fusion, transporters, oxidation-reduction, etc. [9]. Small
RNAs derived from tRNAs and rRNAs have also been reported [14]. Some of the functions
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described for these EVs include the increase in heart parasitism and the immunomodulation
of the host response [15]; the evasion of innate immunity [16]; and the induction of the release
of EVs by the host blood cells that are involved in inhibiting complement-mediated lysis
[17]. Also, EVs may be involved in parasite adhesion to host cells and host-cell invasion
[15,17–20]. Recently, EVs have proved useful in evaluating disease severity as well as vaccine
and drug effectiveness against chagasic cardiomyopathy [21]. However, little is known about
the capacity of EVs to modulate the host-cell conditions. In this sense, the present work seeks
to elucidate certain effects exerted by T. cruzi EVs over the parasite establishment inside the
host cell.
Methods
Cell cultures, parasite strains, and isolation of EVs
Vero (ECACC 84113001) and 3T3 cells (CRL 1658) were cultured in Nunc cell-culture flasks
of 75 cm2 surface area (Thermo Fischer Scientific, USA) in Modified Eagle’s Medium (MEM)
(Sigma, USA) supplemented with 10% foetal bovine serum (Gibco, USA) previously inacti-
vated at 56˚C for 30 min (IFBS) plus antibiotics (penicillin 100 U/mL, streptomycin 100 μg/
mL). The cultures were maintained at 37˚C, in a moist atmosphere enriched with 5% CO2.
HL-1 cardiac muscle-cell line was grown as described above, using Claycomb medium supple-
mented with 10% IFBS, norepinephrine 0.1 mM, L-glutamine 2 mM and antibiotics (penicillin
100 U/mL, streptomycin 100 μg/mL). The cell cultures were routinely monitored for Myco-
plasma by PCR.
Vero cells were initially infected with purified metacyclic trypomastigotes of the Pan4 (Tc
Ia + Tc Id) strain of T. cruzi obtained in vitro, according to de Pablos et al. (2011) [22]. After
120 h of the intracellular development of the parasite, tissue-culture cell-derived trypomasti-
gotes (TcT) were harvested by centrifugation. Parasites were collected routinely every 120 h
from the infected cell monolayer. The culture medium was centrifuged at 3,000 xg for 5 min
and the pellet with the parasites was washed in PBS four times.
To obtain the EVs from the TcT, we followed the procedure described previously by de
Pablos et al. (2016) [18], with some modifications. Parasites were incubated for 5 h at 37˚C in
RPMI medium (Sigma, USA) buffered with 25 mM HEPES at 7.2 and supplemented with 10%
exosome-free IFBS. Afterwards, parasites were removed by centrifugation at 3,500 xg for 15
min and the supernatant was collected and centrifuged at 17,000 xg for 30 min at 4˚C. This
supernatant was filtered through a 0.22 μm pore filter (Sartorius, Germany) and ultracentri-
fuged at 100,000 xg for 16–18 h to obtain the EVs (mostly exosomes). All the steps were per-
formed in an ultracentrifuge Avanti J-301 (Beckman Coulter, USA) with a JA-30.50 Ti rotor.
The resulting pellet was washed three times in PBS in an ultracentrifuge Sorwal WX80
(Thermo Fisher Scientific, USA) with F50L-24 x 1.5 fixed-angle rotor and resuspended in
100 μL PBS.
The isolation procedure was evaluated by Transmission Electron Microscopy (TEM),
Nanoparticle Tracking Analysis (NTA) and Dynamic Light Scattering (DLS). The proteins
from the EVs were quantified using the Micro-BCA protein assay kit (Thermo Fischer Scien-
tific, USA), using bovine-serum albumin as standard. Viability of the TcT after shedding of
EVs was evaluated using the trypan blue exclusion test. After 5 h, no significant death was
detected and over 99% of the parasites were viable.
To demonstrate the specificity of the effects of the EVs from the TcT of T. cruzi and to eval-
uate the effect of the EVs of trypomastigotes of the Pan4 strain over the infection of cells with
T. cruzi from a different DTU and another intracellular microorganism, we performed the iso-
lation of EVs from Crithidia mellificae and the 3T3 cell line (a fibroblast cell line) and evaluated
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the effect of these EVs over the parasitization percentages of cells infected with T. cruzi Pan4.
We also employed T. cruzi 4162 strain (Tc IV) and tachyzoites of Toxoplasma gondii RH for
the infection of cells previously incubated with EVs of T. cruzi Pan4.
For the isolation of EVs from choanomastigotes of Crithidia mellificae, 1x107 parasites were
incubated for 24 h at 28˚C in LIT medium. Nunc cell-culture flasks of 75 cm2 surface area
(Thermo Fischer Scientific, USA) with confluent monolayers of 3T3 cells were washed 3 times
with MEM without IFBS and the cells were incubated for 24 h at 37˚C with MEM (Sigma,
USA). After 24 h of incubation, the culture media were collected and centrifuged at 3,500 xg
for 15 min and the obtained supernatants were handled the same way as for the isolation of
EVs from TcT. DLS and the quantification of the protein concentration of these samples using
the Micro-BCA protein assay kit (Thermo Fischer Scientific, USA) were performed as
described above.
The purification of metacyclic trypomastigotes of T. cruzi 4162 strain was also performed
according to de Pablos et al. (2011) [22] and TcT were obtained after the infection of Vero
cells as described. Tachyzoites of Toxoplasma gondii RH strain were maintained in our labora-
tory by serial passage, in semiconfluent monolayers of Vero cells and cultured in the same con-
ditions as T. cruzi. The egressed parasites were harvested, centrifuged at 5,000 xg for 10 min,
washed three times in PBS and added to the cell cultures in a ratio 5:1 (parasites:cell).
Transmission electron microscopy
To confirm the presence of EVs in our samples, we resuspended an aliquot of the pellet in 0.1
M Tris HCl (pH 7.2) and 5 μL each sample were adsorbed directly onto Formvar/carbon-
coated grids and stained with 2% (vol/vol) uranyl acetate, for the direct observation in a TEM,
LIBRA 120 PLUS Carl Zeiss microscope. The diameter of the EVs was measured by ImageJ
1.41 software.
Nanoparticle Tracking Analysis (NTA) and Dynamic Light Scattering
(DLS)
Distribution, size, and concentration of T. cruzi EVs from trypomastigotes was determined by
measuring the rate of Brownian motion according to the particle size, using a Nanosight
NS300 (Malvern Instruments, UK). This system was equipped with a sCMOS camera and a
blue 488 nm laser beam. Samples were diluted 1/100 just before the analysis, in low-binding
Eppendorf tubes with PBS and the measurements were performed at 25˚C. For data acquisi-
tion and information processing, we used the NTA software 3.2 Dev Build 3.2.16. The particle
movement was analysed by NTA software with the camera level at 16, slider shutter at 1200,
and slider gain at 146.
To confirm the results obtained by NTA, we also performed Dynamic Light Scattering
(DLS) of the EVs of trypomastigotes, choanomastigotes and cells using a Zetasizer nano ZN90
(Malvern Instruments, UK). Samples were prepared the same way as described for the NTA
and the measurements were also performed at 25˚C. For data acquisition and information pro-
cessing, the Zetasizer Ver. 7.11 software was employed.
Western blotting of EVs of T. cruzi Pan4 to evaluate the presence of
cruzipain, trans-sialidase (TS) and MASPs (SP)
The presence of some molecules without orthologues in other organism and involved in the
invasion process of T. cruzi was evaluated in EVs by Western blotting. Briefly, 300 μg of EVs
isolated from TcT of the Pan4 strain were resolved by SDS-PAGE, transferred to a
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nitrocellulose membrane and blocked overnight with 5% non-fat milk in PBS-0.1% Tween 20.
Primary antibodies anti-cruzipain (1:3,000), anti-TS (mAb 39) (1:1,000), and anti-MASPs (sig-
nal peptide, SP) (1:1,000) [16] were incubated overnight at 4˚C. The membranes were washed
with PBS-0.1% Tween 20 and incubated for 1 h with goat anti-mouse IgGs conjugated with
peroxidase (1:1,000) (Dako Agilent Pathology Solutions, USA) in the case of TS and MASPs
and goat anti-rabbit IgGs conjugated with peroxidase (1:2,000) in the case of cruzipain (Dako
Agilent Pathology Solutions, USA). The reaction was visualized using Clarity ECL Western
substrate (BioRad, Spain) in a ChemiDoc Imaging system (BioRad, Spain).
Optimization of EV-cell incubation conditions and invasion assays
Cultures of 5x104 Vero cells were grown in MEM supplemented with 10% IFBS over round
13-mm coverslips (Marienfeld, Germany), in Nunc 24-well plates (Thermo Fischer Scientific,
USA) for 24 h at 37˚C and 5% CO2. After this time, coverslips with cells were washed 3 times
in MEM and incubated for 2 h with 0.1, 0.25, 0.5, 1 and 2.5 μg/mL EVs in MEM. After the
incubation, cells were infected with T. cruzi trypomastigotes of the Pan4 strain, at a parasite:
host cell ratio of 5:1. After 4 h, parasites were removed and the cells were washed and main-
tained in culture for 24 h. The cultures were fixed with methanol and stained with Giemsa.
Parasitization percentages and parasitization indexes (number of amastigotes per cell) were
calculated after counting at least 400 cells.
The invasion assays were also performed using T. cruzi EVs submitted to thermal and
chemical treatments. For the thermal treatments, EVs were incubated in a water bath at 50˚C,
70˚C, and 90˚C for 30 min. For the chemical treatments, EVs were incubated with the proteo-
lytic enzymes trypsin (0.5 mg/mL) and proteinase K (0.5 mg/mL) for 1 h at 37˚C and with
sodium periodate (10 mg/mL) for 20 h at room temperature, in the dark, to reduce the glyco-
conjugates surrounding the EVs. After the treatments, EVs were washed twice in PBS by ultra-
centrifugation at 100,000 xg for 1 h, incubated with the Vero cell cultures for 2 h. The protocol
for cell infection was followed as described above.
The specificity of the effects of the EVs isolated from trypomastigotes of T. cruzi Pan4 and
the effect of EVs from TcT of the Pan4 strain over the invasion of another T. cruzi strain and
intracellular parasite were evaluated. For these experiments, cultures of 5x104 Vero cells were
grown the same way as described for the invasion assays using the Pan4 strain. The cells were
incubated for 2 h at 37˚C with 0.38 μg/mL EVs from Crithidia mellificae or 3T3 cells. After this
time, the cells were infected with T. cruzi trypomastigotes of T. cruzi Pan4 (parasite:host cell
ratio of 5:1) and after 4 h of interaction, the parasites were removed. The cells were washed
and maintained in culture for 24 h, when they were fixed with methanol and stained with
Giemsa. Parasitization percentages and indexes were calculated.
The effect of EVs of the Pan4 strain of T. cruzi over the infection of cells with trypomasti-
gotes of T. cruzi 4162 strain (Tc IV) and tachyzoites of T. gondii RH were performed. In this
case, cells were incubated for 2 h with EVs of T. cruzi Pan4 and then infected with trypomasti-
gotes of T. cruzi 4162 strain or tachyzoites of T. gondii RH in a parasite:cell ratio of 5:1. After 4
h, the parasites were removed, the cells were washed and maintained in culture for 24 h. Para-
sitization percentages and indexes were calculated after the evaluation of the cells by Giemsa
stain.
Changes in cell permeability by T. cruzi EVs
To assess the potential capacity of EVs to permeabilize cells, we cultured 5 x 104 Vero cells in
12-well plates as described above. The potential changes in permeability during or after the
EVs-cell interaction was evaluated using the Aspergillus giganteus ribotoxin α-sarcin, a ~17
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kDa protein that inhibits protein biosynthesis when the cells are previously permeabilized
[23–25]. Briefly, after 24 h of culture, cells were washed 3 times with MEM and incubated with
0.38 μg/mL EVs in MEM for 2 h. Cells were washed once and 20 μM of α-sarcin (Sigma, USA)
was added for 4 h. After this time, cells were washed 4 times and subsequently incubated with
MEM supplemented with 10% IFCS. In a parallel assay, the EVs and α-sarcin were added
simultaneously to the cell culture. Viability of the cells was determined using the trypan blue
exclusion test as well as the MTT viability assay (Sigma, USA). Cell viability was also deter-
mined after the incubation of the cell cultures with EVs, α-sarcin and cells without any treat-
ment as negative controls.
The HL-1 cell line was derived from atrial cardiomyocytes is a cell line that maintains a
series of cardiac characteristics such as morphological, biochemical, and electrophysiological
properties in vitro [26]. On round 13-mm coverslips, 5x104 cells were grown in Claycomb
medium supplemented with 10% IFBS, norepinephrine 0.1 mM, L-glutamine 2 mM and anti-
biotics. After 24 h of culture, cells were washed and incubated with 0.38 μg/mL EVs in MEM
for 2 h. Afterwards, coverslips were washed 3 times and fixed with a solution of 2% parafor-
maldehyde and 1% glutaraldehyde for 1 h, washed 3 times in PBS and blocked with a solution
containing 1% BSA and 0.3 M glycine in PBS, for 1 h. Cells were washed 3 times and incubated
with an anti-β2-adrenergic receptor primary antibody (1:500) (Thermo Fisher Scientific, USA)
for 1 h. Afterwards, cells were washed 3 times and incubated in the dark, with a goat anti-rab-
bit IgG antibody conjugated with Alexa Fluor 647 (1:500) (Thermo Fisher Scientific, USA) for
1 h, at 37˚C. Finally, samples were washed 4 times, mounted in Vectashield mounting medium
with DAPI (Vector Laboratories, USA) and imaged with a Leica DM5500B inverted micro-
scope (Leica Microsystems, Germany).
HL-1 cells cultured and fixed as described above but treated with a solution of NP-40 in 10
mM citric acid (pH 6) were employed as positive control of permeabilization of the assay.
Intracellular mobilization of Ca2+ induced by T. cruzi EVs
Vero cells were grown overnight in MEM without phenol red plus IFBS and in MEM without
phenol red plus IFBS and 2.5 μM EDTA, on μ-slide ibidi multichamber dishes. Cells were
washed 3 times in MEM without phenol red and incubated at 37˚C for 20 min with Fluo4-AM
(Thermo-Fisher, USA) in 1) MEM without phenol red, 2) MEM without phenol red plus
2.5 μM EDTA and 3) a culture medium similar to MEM but without Ca2+ and Mg2+. Fluo-4 is
an indicator that exhibits greater fluorescence upon binding intracellular free Ca2+. It presents
an AM grouping (acetoxymethyl ester) that, when internalized, is cleaved by intracellular
esterases and released to bind to cytoplasmic calcium [20].
After 20 min of incubation of the cells with Fluo-4 AM, EVs of TcT of T. cruzi Pan4 were
added to the cells and followed-up in time until 25 min of interaction. Basal controls of fluores-
cence in cells before the application of the stimulus with EVs were included.
Images were taken every 5 min with a confocal microscope Nikon A1 (Nikon Instruments,
The Netherlands) equipped with 10x, 20x multi-immersion, 40x oil, 60x oil, and 60x water
objectives and a system of cell incubation at 37˚C with enriched atmosphere with 5% CO2.
The Fluo4 probe was excited at 494–506 nm and light emission was detected at 516 nm. The
fluorescence intensity was analysed and normalized with reference to the basal fluorescence
using NIS Elements Software (Nikon Instruments, The Netherlands). The analysis of images
was performed using Fiji software (Fiji is Just Image J). Controls of cells incubated with
A23187 (a calcium ionophore) and 3-isobutyl-1-methylxantine (IBMX) (a non-specific inhibi-
tor of cAMP and cGMP phosphodiesterase that induces calcium release from intracellular
stores) were included.
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Effects of the EVs of T. cruzi over the actin cytoskeleton integrity
Cultures of 5x104 Vero cells were seeded over round 13-mm coverslips (as described above)
and allowed to attach to the coverslips overnight. The cells were washed 3 times with MEM
and incubated in MEM during different times with 0.38 μg/mL EVs in MEM. After this incu-
bation step, coverslips were washed 3 times and fixed with cold acetone (Scharlab, Spain) for
15 min at -20˚C. After the fixation step, coverslips were washed 3 times with PBS and permea-
bilized in a solution of 0.1% Triton X-100 (Sigma, USA) for 10 min. The cells were washed 3
times and blocked with 1% BSA and 0.3 M glycine in PBS for 1 h in PBS. After this time, the
cells were washed and incubated with 5 μg/mL of a vimentin polyclonal antibody (1:300)
(Thermo Fischer Scientific, USA) for 1 h, washed 4 times and incubated in the dark, with a
goat anti-rabbit IgG antibody conjugated with Alexa Fluor 647 (1:500) (Thermo Fisher, USA)
for 1 h, at 37˚C. The coverslips were washed 4 times and stained with a solution of phalloidin,
fluorescein isothiocyanate labelled (Sigma, USA) for 30 min. Samples were finally mounted in
Vectashield mounting medium with DAPI (Vector Laboratories, USA) and imaged in a Leica
DM5500B inverted microscope (Leica Microsystems, Germany). Images were captured 15
min, 30 min, 120 min, and 24 h after EVs-cell contact. Cells not treated with EVs and cells
incubated with the final supernatant from the EVs purification medium were employed as
controls.
Cell cycle analysis: Flow cytometry and Western blotting of the
phosphorylated and non-phosphorylated protein of Retinoblastoma (pRb)
Vero cells (1x105) were synchronized according to the method described previously by Osuna
et al. (1984) [27]. Cells were seeded in 6-well plates with a culture medium with 25 mM thymi-
dine for 12 h, when the medium was replaced with MEM + 10% IFCS. Afterwards, cells were
washed with MEM and 1 h later, EVs were added directly to each well. One hour after this EV-
cell contact, cells were washed and maintained for 2 and 8 h. Afterwards, the culture medium
of the corresponding wells was removed, the cells were washed with PBS, fixed with 70% cold
ethanol and incubated with a solution (0.2 M Na2HPO4, 0.1 M citric acid, pH 7.8) for 15 min
at 37˚C. Cells were then centrifuged, washed with PBS and resuspended in 250 mL of a solu-
tion of propidium iodide (40 mg/mL) and RNAse (100 mg/mL) for 30 min at 37˚C in the
dark, according to Carrasco et al. (2014) [28]. Finally, the samples were analysed in a FACS
Calibur (BD Biosciences, San Jose, CA, USA) flow cytometer. The results were analysed with
FlowJo software (v 7.6.5, Tree Star, Inc.).
Phosphorylation of the protein Rb after the incubation of cells with EVs was evaluated by
immunoblotting. Briefly, 1x105 cells were grown in 6-well plates for 24 h. Cells were washed
with MEM and incubated with EVs for 5, 10, 30 and 60 min. After this session, the cells were
washed with PBS and lysed in RIPA lysis buffer with a protease inhibitor cocktail (Roche, Swit-
zerland) for 15 min. Cells were harvested with a cell scraper and centrifuged at 14,000 xg for
10 min at 4˚C. Supernatants were transferred to new Eppendorf tubes and stored at -20˚C.
The protein from cell lysates was quantified using the Bradford reagent (Sigma, USA) and
90 μg of protein from cell lysates were resolved by SDS-PAGE, transferred to a nitrocellulose
membrane and blocked overnight with 5% non-fat milk in PBS-0.1% Tween 20. Rb (1:2,000)
and phospho-Rb (1:1,000) (Cytoskeleton, USA) primary antibodies (Sigma, USA) were incu-
bated overnight at 4˚C. Tubulin antibody (1:5,000) (Cytoskeleton, USA) was used as the load-
ing control. The membranes were washed with PBS-0.1% Tween 20 and incubated for 1 h with
goat anti-mouse IgGs conjugated with peroxidase (1:1,000) (Dako Agilent Pathology Solu-
tions, USA) in the case of Rb, goat anti-rabbit IgGs conjugated with peroxidase (1:2,000) in the
case of phospho-Rb (Dako Agilent Pathology Solutions, USA), and rabbit anti-sheep IgGs
EVs of T. cruzi trypomastigotes: Physiological changes in non-parasitized cells
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007163 February 21, 2019 7 / 26
conjugated with peroxidase (1:5,000) (Dako Agilent Pathology Solutions, USA) in the case of
tubulin. The reaction was also visualized using Clarity ECL Western substrate (BioRad, Spain)
in a ChemiDoc Imaging system (BioRad, Spain).
Statistical analysis
Quantification values represent the means of two or more independent experiments, each per-
formed in triplicate. Means and standard deviations of the EVs size (NTA), percentage of
infected cells (invasion assays) and percentage of live cells (permeabilization assays) were cal-
culated. One-factor ANOVAs were performed to detect significant differences between cells
treated with EVs and control cells in the case of permeabilization and cell-cycle assays. Multi-
ple post hoc comparisons were performed using the Tukey-Kramer test on GraphPad Prism 5
Software (USA). Values with p<0.0001 were considered statistically significant (���).
Results
Transmission electron microscopy, NTA and DLS of EVs of T. cruzi
After the incubation of 1x107 trypomastigotes of the Pan4 strain for 5 h at 37˚C in the culture
medium for the release of EVs, 12 μg of total protein of EVs were obtained. The isolation of
the EVs by the ultracentrifugation protocol described was evaluated by TEM, NTA and DLS
and the presence of surface molecules of T. cruzi in these samples was confirmed by Western
blotting (S1 Fig).
Most of the particles visualized by negative staining under TEM were of 30–100 nm size
(S1A Fig). Analyses by NTA revealed a majority of EVs with a size of 70.7 ± 7.3 nm (S1C Fig)
and a concentration of approximately 5x1010 ± 3.9x109 particles/mL. In the DLS analyses, two
populations of EVs with different sizes were observed for TcTs, choanomastigotes and 3T3
cells (S1D, S1E and S1F Fig); EVs of T. cruzi showed a population of 23.05 ± 6.96 nm and a
population of 55.74 ± 13.97 nm (S1D Fig). Western blotting confirmed the presence of cruzi-
pain, trans-sialidase and MASPs (SP) in the EVs of T. cruzi Pan4 (S1B Fig).
Invasion assays
To evaluate the effect of EVs of TcT from the Pan4 strain in host-cell invasion, we tested differ-
ent doses measured in total μg/mL of protein. After 2 h of incubation of the cells with the
EVs, the infection with T was performed in a ratio 5:1 (T:cell) for 4 h. Counts were performed
24 h later, as described in the Methods section. The results indicate that the parasitism
increased the most when the cells were treated with 0.5 μg/mL of EVs. These values in percent-
age of parasitization (88.88 ± 3.73) significantly differed with respect to the other doses ana-
lysed (S2A Fig). From these results, the Effective Dose 50 (ED50) for subsequent trials was set
as 0.38 μg/mL.
Regarding the effect of EVs on cells over time (the increase in cell parasitization), these
were treated with 0.38 μg/mL of total protein of EVs for 2 h. After the cells were washed three
times in medium without serum, they were infected at different time points after the treatment
with EVs at a T:cell ratio 5:1, as described above. The results (S2B Fig) show that the difference
between the percentage of parasitization of the cells treated with the EVs vs. the percentage of
parasitization of non-treated control cells were statistically significant up to 8 h after the treat-
ment. The effects were more evident at 2 and 4 h, when the increase in the percentages was
higher compared to untreated cultures. This effect was not appreciated when the cells were
infected 24 h after the treatment with the EVs. The parasitization indexes (number of parasites
per cell) calculated also differed. For example, in the case of the cells incubated with EVs for 2
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h was 2.78 ± 0.55, an index that was twice the parasitization index of the control infected cells
without the previous treatment (1.33 ± 0.18).
A series of experiments were performed to study whether the thermal treatment, the treat-
ment with proteolytic enzymes or the reduction of the glycoconjugates surrounding the EVs
alters their ability to induce higher levels of parasitization in the host cells with which they
interact. Results are shown in S2C and S2D Fig. The thermal treatment of the EVs at 50˚C,
70˚C and 90˚C annuled the action of the EVs on the cells, so the increase in the percentage of
parasitization was not observed. The enzymatic treatment with the two proteases employed
and the treatment with sodium periodate (for the reduction in the content of carbohydrates of
the EVs) also inhibited the capacity of increasing the cell parasitization by trypomastigotes of
T. cruzi in the cultures.
Finally, Fig 1A, 1B and 1C show the effect of the incubation of cells with EVs of C. mellificae
and 3T3 cells prior to the infection with T. cruzi Pan 4 and the increase in the infection of cells
when these are incubated with EVs isolated from trypomastigotes of the Pan4 strain and then
infected with TcT of the 4162 strain or tachyzoites of T. gondii RH. In Fig 1A is possible to
observe that the incubation of cells with EVs from another source different than T. cruzi did
not boosted an increase in the percentage of infected cells as it happens when the cells are in
contact with EVs of T. cruzi Pan4 prior to the infection. When the cells were incubated with
EVs of C. mellificae and 3T3 cells, the percentage of infected cells obtained were 29.3 ± 5.0 and
29.8 ± 4.3, respectively. These results did not differ significantly from the results obtained in
the case of the cells infected only with TcT of T. cruzi Pan4 without the previous treatment
with the EVs (36.5 ± 3.8). In these experiments, the parasitization indexes obtained were
1.31 ± 0.08 in the cells incubated with EVs of C. mellificae, 1.79 ± 0.28 in the cells incubated
with EVs of the 3T3 cell line and 1.54 ± 0.31 in the cells infected with TcT without the prior
incubation with EVs, but it rose to 2.60 ± 0.14 when the cells were previously treated with EVs
of T. cruzi Pan4. This Figure also shows that this increase in the parasitization percentage and
index of cells is independent of the strain of T. cruzi employed to infect the cells, as we proved
that the infection with TcT of a strain that is classified as Tc IV almost doubled the percentage
of infected cells not incubated previously with the EVs (53.5 ± 6.0 vs 32 ± 2.6; parasitization
indexes: 2.10 ± 0.14 vs 1.39 ± 0.21, respectively).
In the case of the cells treated with EVs of T. cruzi Pan4 prior to the infection with tachy-
zoites of T. gondii RH, in Fig 1B is possible to observe a slight, non-significant increase in the
percentage of infected cells in those incubated with EVs of T. cruzi prior to the infection with
tachyzoites, when compared to the cells infected with the parasite without the previous incuba-
tion with the EVs of T. cruzi (56.50 ± 4.80 vs. 46.50 ± 4.93).
EVs of T. cruzi induce cell permeabilization of Vero and HL-1 cells
A toxin of Aspergillus giganteus, α-sarcin, constitutes a ribotoxin with a molecular weight of
16.8 kDa that acts at the ribosomal level, inhibiting the protein synthesis. This toxin has been
used to determine the potential permeabilization induced in the cells on the entry of certain
viruses [29]. The cells were treated in two ways: i) they were simultaneously incubated with
EVs of T. cruzi Pan4 and α-sarcin or ii) they were incubated with EVs of T. cruzi Pan4 for 2 h
and then with α-sarcin for 4 h. After 24 h of the treatment, the trypan blue exclusion assay was
performed. Vero cells treated with EVs and α-sarcin registered mortality percentages of
76.10 ± 6.81 (simultaneous incubation) and 82.20 ± 10.17 (separated incubation of EVs and
the toxin). The control cells incubated only with the toxin or with the EVs showed mortality
percentages of 16.90 ± 4.10 and 17.23 ± 7.73, respectively, while the percentage of viability of
the untreated control culture cells was 15.56 ± 7.67. These results were confirmed using the
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MTT cell-viability assay, as shown in Fig 2A. In this case, the percentage of viability of the cells
treated with EVs and the toxin was 37.36 ± 15.39, while the same percentages in the cells
treated only with the toxin or the EVs alone were 90.10 ± 7.03 and 95.30 ± 3.30, respectively.
The percentage of viability in the untreated control cell cultures was 99,0 ± 0.1. Fig 2B shows
the appearance of the different cell monolayers preincubated with EVs and treated with α-sar-
cin and the different control cells at 24 h of the treatment.
The beta-2 adrenergic receptor (β2 adrenoreceptor), also known as ADRB2, is a cell mem-
brane-spanning beta-adrenergic receptor that binds epinephrine or adrenaline, whose signal-
ling, via a downstream L-type calcium channel interaction, mediates physiological responses
such as smooth-muscle relaxation and bronchodilation [30]. Using an antibody that recog-
nizes an epitope between the amino acids 340–413 (which corresponds to the intracytoplasmic
domain of the receptor), we demonstrated that the EVs of T. cruzi can alter and permeabilize
the cell membrane, exposing the epitope to the antibody, as shown in Fig 2C. In the case of the
untreated cells, this effect was not detected. An image similar to that of the cells treated with
the EVs resulted in the cultures that, prior to the incubation with the antibody, were permeabi-
lized with a solution containing NP-40.
EVs of T. cruzi induce the intracellular mobilization of Ca2+
The time-course measurements of the intracellular calcium levels of Vero cells treated with the
EVs of T. cruzi Pan4 are shown in Fig 3. Results show that, when the cells were incubated in a
culture medium with Ca2+ and Mg2+, the fluorescence levels increased up to 3.83 ± 0.62 times
the initial values as soon as 10 minutes of interaction. Moreover, when the interaction was per-
formed in a culture medium depleted of Ca2+ and Mg2+, there was also a progressive increase
in the fluorescence levels. For example, at 10 min of the interaction, there was a 1.40 ± 0.39-
fold increase in the fluorescence levels of the cells, which could correspond to a mobilization
of the ions from their intracellular deposits to the cytoplasm.
In the case of the cells incubated in MEM with EDTA, a calcium chelator, there was also a
1.69 ± 0.01 increase in the fluorescence levels at 10 minutes of incubation, when the
Fig 1. Invasion assays in Vero cells pre-incubated with EVs. The specificity of the effects of EVs of T. cruzi in increasing the percentages of
parasitization is shown in A. The percentages of Vero cell parasitization after the incubation with EVs of C. mellificae and 3T3 cells and the
latter infection with trypomastigotes of T. cruzi Pan4 were also calculated. In this case, the incubation of cells with EVs from another source
different than T. cruzi did not generate an increase in the percentage of infected cells or in the parasitization indexes, as happens when cells are
in contact with EVs of T. cruzi prior to the infection. In these experiments, the parasitization indexes obtained were 1.31 ± 0.08 in the case of the
cells incubated with EVs of C. mellificae, 1.79 ± 0.28 in the case of the cells incubated with EVs of the 3T3 cell line and 1.54 ± 0.31 in the case of
the cells infected with TcT without the incubation with EVs, but it rose to 2.60 ± 0.14 when the cells were previously incubated with EVs of T.
cruzi. Moreover, the percentage of Vero cell parasitization after the incubation with EVs of T. cruzi Pan4 and the latter infection with
trypomastigotes of T. cruzi 4162 was evaluated. This Fig also shows that these increases in the percentages of parasitization and the
parasitization indexes of the cells don´t depend on the strain of T. cruzi employed to infect the cells, as the percentage of infected cells with the
strain 4162 almost doubled the percentage of infected cells not incubated previously with the EVs (parasitization indexes: 2.10 ± 0.14 vs
1.39 ± 0.21, respectively). Vero cells were also incubated for 2 h with EVs of T. cruzi Pan4 prior to the infection with tachyzoites of T. gondii RH
(B). Results show a slight, non significant increase in the percentage of parasitization in the case of the cells incubated with EVs of T. cruzi prior
to the infection with the tachyzoites, when compared to the cells only infected with the parasite (56.50 ± 4.80 vs. 46.50 ± 4.93); a) Giemsa stain
of Vero cells incubated with EVs of T. cruzi Pan4 and infected with tachyzoites of T. gondii RH; b) Giemsa stain of Vero cells infected with
tachyzoites of T. gondii RH (low magnification fields, 20x). Images that illustrate the effect of T. cruzi EVs in increasing the percentage of
parasitization of Vero cells by Giemsa stain are shown in C. Vero cells were incubated with EVs of C. mellificae (a), EVs of 3T3 cells (b) and EVs
of TcT of T. cruzi Pan4 (c, d) and then infected with TcT of T. cruzi Pan4 (a, b, d) of TcT of T. cruzi 4162 strain (c). Cells incubated only with
EVs of C. mellificae (e), EVs of 3T3 cells (f), EVs of TcT of T. cruzi Pan4 (g) and control cells (without incubation) (h) were also included. Low
magnification fields (20x) were taken in order to show the overall effect of the different treatments on the cell culture. A magnification field of
40x is included for the incubation of cells with EVs of C. mellificae and then infected with trypomastigotes of the Pan4 strain (i), cells incubated
with EVs of TcT of T. cruzi Pan4 and then infected with trypomastigotes of the Pan4 strain (j), cells infected only with TcT of T. cruzi Pan4 (k)
and cells only incubated with EVs of TcT of T. cruzi Pan4 (l). Black arrows illustrate some Vero cells infected with T. cruzi. The values are the
mean percentages ± SEM. Tukey-Kramer test, p<0.0001 (���); Ns: non-significant differences.
https://doi.org/10.1371/journal.pntd.0007163.g001
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Fig 2. Cell permeabilization of Vero and HL-1 cells by EVs of T. cruzi Pan4. A cell-viability assay to evaluate the entry of α-sarcin in Vero cells
after the incubation with EVs of T. cruzi using MTT was performed (A). Cells were incubated with T. cruzi EVs for 2 h, washed, and then
incubated with the toxin α-sarcin for 4 h. The MTT cell viability assay was performed at 24 h of the incubation with EVs, following the
manufacturer’s instructions. Cells treated only with α-sarcin, EVs and untreated cells were used as controls. The cell monolayers incubated with
EVs, α-sarcin or both are shown in B; a) control Vero cells; b) Vero cells treated with EVs for 2 h; c) cells treated with α-sarcin (20 μM) for 4 h; d)
cells treated with EVs for 2 h and then treated with α-sarcin (20 μM) for 4 h. The cell cultures were examined at 24 h of the treatment. Low
magnification fields were taken in order to show the overall effect of the different treatments on the cell culture. Permeabilization was also
evaluated in HL-1 mouse cardiomyocyte cells (C); a) HL-1 mouse cardiomyocyte cells incubated with T. cruzi EVs for 2 h, fixed in a solution of
paraformaldehyde/glutaraldehyde for 1 h and incubated with the anti-β2-adrenergic receptor antibody (antiβ2R); b) HL-1 mouse cardiomyocyte
cells not incubated with the EVs, fixed with paraformaldehyde/glutaraldehyde for 1 h and incubated with the anti-β2R (control); c) HL-1 mouse
cardiomyocyte cells not incubated with the EVs, fixed with paraformaldehyde/glutaraldehyde for 1 h and permeabilized in a solution of NP-40 in
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fluorescence intensity started to decrease. At this point, it is possible to observe a different pat-
tern of distribution of the fluorescence, with the appearance of a more granulated cytoplasm.
The calcium ionophore A23187 was used as the control for the assays of the cells incubated
in the medium containing Ca2+ and Mg2+ and prompted a 64.80-fold rise in the fluorescence
levels at 25 min. The cAMP phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX)
was used as the control for the induction of ion output from the intracellular Ca2+ deposits to
the cytoplasm and prompted a 2.37-fold rise in the fluorescence levels at 10 min.
EVs of T. cruzi disrupt the actin cytoskeleton
The analysis of the effect of the EVs of T. cruzi Pan4 over the actin cytoskeleton is shown in Fig
4A, 4B and 4C. The disorganization of the actin filaments was visible in the cells showing
greater globular actin (GA) from 15 min up to 120 min after the treatment with EVs (Fig 4A,
4B and 4C). On the other hand, vimentin appeared to withdraw from the areas in the cyto-
plasm where the actin is disorganized and concentrated in the parts of the cytoplasm where
GA is less patent. The morphology of the treated cells appeared to be altered and filopodia (F)
were visible, giving a dendritic aspect to the cell. These effects were reversible 24 h after the
treatment; both the cytoskeleton images and the morphology of the cells incubated with EVs
were similar to that of the control cells not treated with EVs.
EVs of T. cruzi arrest of the cell cycle in phase G0/G1
The influence of the EVs of T. cruzi Pan4 on Vero cells cycle was analysed with Vero cells pre-
viously synchronized in the S phase and treated as described in Methods. The changes in the
cell cycle were analysed by flow cytometry 2 and 8 h after the addition of the EVs. Fig 5A
shows the percentage of cells in the different phases of the cell cycle. At 8 h after the addition
of the EVs, the percentage of cells increased at phases G0/G1 and decreased at phase S.
Fig 5B and 5C show the results of the levels of the protein of retinoblastoma (pRb) in its
phosphorylated and non-phosphorilated states, in the cells treated with EVs of T. cruzi Pan4
and the untreated control cells. The protein expression increased for the phosphorylated pRb
from the first minutes of the interaction of the EVs with the cells, reaching the maximum
phosphorylated state at 15 min of the interaction and declining to values similar to those of the
control cells at 60 min of treatment.
Discussion
The cell-invasion process of T. cruzi has been widely studied. Numerous mechanisms are
known to be involved in preparing the cell to induce the endocytosis of trypomastigotes into
non-phagocytic cells [31–36] and among the natural agents that induce massive entry and cel-
lular infection are the EVs secreted by trypomastigotes.
EVs from trypomastigotes of the Pan4 strain were first isolated in 2016, when de Pablos
et al. confirmed that the C-terminal region of MASPs proteins is present in the EVs secreted
by the trypomastigotes derived from tissue-culture cells [18]. Following the methodology
described above using differential centrifugation and then Nanoparticle Tracking analysis, we
obtained an homogeneous population of EVs under our experimental conditions. Also, the
yield was higher than that of other authors using others strains or forms of the parasite. Trocoli
10 mM citric acid (pH 6) prior to the incubation with the antiβ2R; d) HL-1 mouse cardiomyocyte cells incubated with T. cruzi EVs for 2 h, fixed
with paraformaldehyde/glutaraldehyde for 1 h, permeabilized in a solution of NP-40 in 10 mM citric acid (pH 6) and incubated with the
(antiβ2R) (control). The values are the mean percentages ± SEM. Tukey-Kramer test, p<0.0001 (���); Ns: non-significant differences.
https://doi.org/10.1371/journal.pntd.0007163.g002
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Fig 3. Analyses of the intracellular Ca2+ mobilization in Vero cells incubated with EVs of T. cruzi. Cells were incubated with Fluo4-AM, washed, and then
incubated with EVs of T. cruzi, with examination every 5 min using confocal microscopy. When the cells were incubated in a culture medium with Ca2+ and Mg2+,
the fluorescence levels progressively increased up to 3.83 ± 0.62 times the initial values as soon as 10 minutes of the interaction (red line). At the same time point,
when the cells were incubated with EVs in a culture medium depleted of Ca2+, there was an increase of 1.40 ± 0.39 times in the fluorescence levels when compared to
the time 0 (blue line). Also, when the cells were incubated with 2.5 μM EDTA, a calcium chelator, there was a 1.69 ± 0.01 increase in the fluorescence levels at 10 min
of incubation, when the fluorescence intensity started to decrease and it was possible to observe a more granulated pattern of fluorescence in the cytoplasm (black
line). The calcium ionophore A23187 and the cAMP phosphodiesterase inhibitor IBMX were employed as the positive controls of the experiment. A23187 prompted
a 64.80-fold rise in the fluorescence levels at 25 min and IBMX prompted a 2.37-fold rise in the fluorescence levels at 10 min of incubation.
https://doi.org/10.1371/journal.pntd.0007163.g003
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Torrecilhas et al. (2009) employed 5 μg of protein from 1x105 trypomastigotes of the Y strain
[15]. Garcia Silva et al. (2014) have reported a protein yield of the vesicular fraction of 1.2 μg
per 1x1010 epimastigotes from the DM28c strain [14]. In our case, we found 12 μg of protein of
EVs after the incubation of 1x107 trypomastigotes of the Pan4 strain for 5 h at 37˚C in the cul-
ture medium for the release of EVs.
To track the time course of the effect of EVs in increasing cell parasitism, we performed
infections at different times after incubating the cells with EVs and we found that the cells are
still susceptible to increased parasitism at least for 8 h after the treatment (p<0.0001). How-
ever, 24 h after the incubation with the EVs, the percentage of infected cells in the treated and
non-treated cultures were similar (S2B Fig). On the other hand, we observed that increasing
amounts of EVs can increase the percentage of infected cells with sigmoidal kinetics, reaching
a maximum of 89% infected cells (0.5 μg/mL) and ED50 of 0.38 μg/mL, a dose that was
employed in subsequent experiments. In 2014, Garcia Silva et al. observed that the treatment
with small amounts of EVs (160 ng) can prevent cells from appearing oversaturated in a tRNA-
Glu-derived 50 halves visualization analysis by FISH [14]. In the same study, the authors deter-
mined that 30 min after the treatment of cells with EVs, a diffuse fluorescent cytoplasmic
pattern appeared, which becomes granular after 2 h of treatment. Regarding the interaction
and posterior infection of the cells after the treatment with the EVs, Cestari et al. (2012) pre-
incubated Vero cells for 30 min before adding the trypomastigotes of the Sylvio X10/6, DTU I
strain [17]. This reflects that the incubation conditions with respect to the amount of EVs used
and the incubation time vary among the different research groups, and it should be taken into
account that the conditions selected by a researcher do not necessarily correspond to the con-
ditions of a natural infection [14].
It has been demonstrated in vitro (in non-phagocytic cells and monocytes), as well as in
vivo, that EVs of T. cruzi increase the number of infected cells [15,17,37–38]. Under our exper-
imental conditions, cells pretreated with EVs of T. cruzi Pan4 registered infection percentages
of over 3.5-fold higher than for cells infected without the prior incubation with the EVs. The
parasitization index (number of parasite per cell) was also two-fold that of the parasitization
index of the control infected cells without prior treatment. In 2009, Trocolli Torrecilhas et al.
reported that T. cruzi trypomastigotes invade 5-fold more susceptible cells when these were
preincubated with purified parasite EVs [15]. Cestari et al. (2012) also demonstrated that
THP-1 derived plasma membrane vesicles (ectosomes) could simultaneously induce an
increase in Vero cell invasion [17]. This invasion was dose dependent, non-specific for parasite
strain or eukaryotic cell line, and dependent on the parasite infective stage. We also proved
that the increase in parasitization is specific to T. cruzi trypomastigotes but non-specific for
the parasite strain and that the incubation of cells with EVs from another trypanosomatid spe-
cies or those from eukaryotic cells didn´t increased the percentages of parasitization.
The interaction EVs-cell and the latter activity of EVs appears to depend on their binding
through lectins to the plasma membrane and on a presumably enzymatic protein activity,
Fig 4. Disruption of the actin cytoskeleton and formation of filopodia in Vero cells incubated with EVs of T. cruzi.
Vero cells were incubated with EVs of T. cruzi Pan4 during different time points (A). The disruption of the actin
filaments is observed since 15 minutes of treatment of the cells with EVs, the formation of filopofia is more evident at
30 min of treatment (�); a) Vero cells incubated with EVs of T. cruzi Pan4 for 15 min; b) Vero cells incubated with EVs
of T. cruzi Pan4 for 30 min. Vero cells incubated with the supernatant of the EVs purification medium (c) and Vero
cells without the EVs treatment (d) were employed as controls of the experiment. A magnification is shown in B; a)
Vero cells incubated with EVs of T. cruzi Pan4 for 15 min; b) Vero cells incubated with EVs of T. cruzi Pan4 for 30
min. In this magnification, white arrows indicate the disorganization of actin filaments and F the formation of
filopodia in the cells. The disruption of the actin cytoskeleton in Vero cells incubated with EVs of T. cruzi for 120 min
is shown in C; a) and b) Vero cells incubated with EVs of T. cruzi Pan4 for 120 min and c) Vero cells without the
incubation with EVs.
https://doi.org/10.1371/journal.pntd.0007163.g004
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given that the thermal and chemical treatments of EVs with trypsin, proteinase K, and sodium
periodate drastically reduced parasitism of the cells with which they interacted. During the
adhesion and invasion process of T to the host cells, a number of glycosylated molecules are
expressed on the surface of the parasite. Examples include mucins, trans-sialidases, MASPs
and the gp85 family of proteins [35]. Glycosylated proteins have also been detected in EVs by
proteomic analyses [9,39] some with important activities and biological significance, such as
trans-sialidases (TS/SAPA, TC85, gp82, gp90, CRP) [40], cruzipain [41], gp63, MASPs [42],
and other types of mucins [43]. As these proteins are located on the surface of the EVs, they
can bind specifically to the proteins in the plasma membrane and this would explain why the
reduction of the carbohydrates of the EVs after the sodium periodate treatment can affect the
binding of EVs to the surface of the cells. On the other hand, some of these glycoproteins have
enzymatic activities essential for the interaction of trypomastigotes during the invasion process
and maybe in the interaction of EVs with the plasma membrane.
It has been reported that the infection with some type of viruses lead to a permeabilization
mechanism where the plasma membrane allows the entry of some high molecular weight mol-
ecules such as α-sarcin (16.8 KDa) [44–46], toxin that lacks a membrane receptor, unlike other
toxins that affect the protein synthesis and are internalized via endocytosis [45,47]. The same
effect was observed incubating cells with EVs of trypomastigotes of T. cruzi, as our results
demonstrate that they can permeabilize Vero and HL-1 cell lines. Cell counts with trypan blue
24 h after the preincubation of cells with EVs and subsequent incubation with α-sarcin regis-
tered as much as 76.10% mortality. The control cells incubated only with α-sarcin, only with
EVs, and without either showed percentages of cell death of 16.90%, 17.23%, and 15.56%,
respectively. The percentages of mortality (100 - % of viability in Fig 2) of the cells using MTT
were 62.64% in the case of the cells previously incubated with EVs and 9.90% in cells incubated
only with the toxin. In 1990, Castanys et al. have reported that infective metacyclic forms of T.
cruzi secrete a glycoprotein involved in cell permeabilization that enabled the entrance of mol-
ecules such as α-sarcin [24].
Permeabilization was also evaluated in HL-1 cardiac muscle cells with confocal microscopy,
using an antibody directed to an epitope of the β2-adrenergic receptor located in the intracyto-
plasmic region of the receptor anchoring. In this experiment, fluorescence was detected in the
cytoplasm of cells previously incubated with EVs and in cells not treated with EVs but permea-
bilized with the detergent NP-40. This permeabilization may be the result of changes in the cell
membrane that allow the direct entry of the antibodies into the cytoplasm or by a transient dis-
organization of the membrane, capable of exposing the antigens present in inside the cell, with
consequent exposure to the immune system. The presence of autoantibodies against β-adren-
ergic receptors in the serum of chagasic patients has been reported [48–51], although authors
have related such emergence to the recognition of exposed parts in the membrane due to cross
reactivity to ribosomal acidic proteins P0 of the parasite [52]. A study related to the recogni-
tion of epitopes of the β-adrenergic receptors inserted into the inner side of the membrane by
autoantibodies would be necessary to confirm the possible hypothesis that the permeabiliza-
tion of the cardiac cells by the parasitic EVs lead to the exposure of these receptors to the
immune system and then elicit the production of autoantibodies.
Fig 5. Arrest of the cell cycle by EVs of T. cruzi Pan4. Vero cells were incubated with EVs of T. cruzi Pan4 for 1 h, and then washed and incubated for 2 and 8 h,
when the flow cytometric analyses were performed (A). At 8 h it is possible to observe an increase in the percentage of cells at phases G0/G1 and a decrease in the
percentage of cells at phase S. The phosphorylation of the pRb in Vero cells incubated with EVs of T. cruzi Pan4 (B) and the expression of the non-phosphorilated pRb
in Vero cells incubated with EVs of T. cruzi Pan4 were also evaluated (C). The values are the mean percentages ± SEM. Tukey-Kramer test, p<0.0001 (���); Ns: non-
significant differences.
https://doi.org/10.1371/journal.pntd.0007163.g005
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The recognition and the invasion processes of the trypomastigotes to the host cells involve
molecules over the surface of both the trypomastigote and the host cell. A ligand-receptor rec-
ognition occurs and generates in both a series of events that raises the intracellular Ca2+ levels
due to the mobilization of the ions from the endoplasmic reticulum and the mitochondria
[53–57]. This boost in calcium levels is also responsible for higher cAMP levels [58], facilitating
the release of EVs and their later fusion with the plasma membrane [59]. The treatment of
Vero cells with EVs of T. cruzi Pan4 raised cytoplasmic Ca2+ levels and to determine the kinet-
ics and origin of these Ca2+ ions, we treated cells with EVs and studied the result every 5 min
under confocal microscopy. From 5 min of the treatment, fluorescence intensified in both cul-
ture media (with and without calcium). This implies that the contact of Vero cells with EVs
raises cytoplasmic Ca2+ levels that could come both from the intracellular deposits of calcium
and the extracellular medium. The fluorescence pattern detected resembles the one in control
cells treated with the xanthine IBMX for the Ca2+ mobilization from the intracellular deposits
[60] or when the cells were incubated with the ionophore A23187 [61], a compound that
allows Ca2+ to enter cells from the culture medium.
It has been demonstrated in different types of eukaryotic cells that the intracellular levels of
calcium induce an asymmetric distribution of phospholipids in the plasma membrane by the
activation of the enzymes scramblase and floppase. Then, phosphatidylserine and phosphati-
dylethanolamine are exposed in the outer side of the membrane and contribute to the activa-
tion of Ca2+-dependent proteases, followed by the release of EVs [62]. The exposure of anionic
phospholipids to EVs strengthens the fusogenic properties of these vesicles, which could be a
prerequisite for the release of the EV content. This could mean that the higher intracellular cal-
cium levels and the changes in the distribution of phospholipids could explain the permeabili-
zation induced in the host cell after the treatment with the EVs of T. cruzi, allowing the
entrance of a toxin of ~17 kDa such as α-sarcin. Moreover, increases in intracellular Ca2+
could trigger a greater release of EVs from the cells exposed to the parasite [3,17,63], as more
calcium prompts a strong response of EV release in other cell lines [64–65].
Calcium ions also contribute to the reorganization of the cytoskeleton through the activa-
tion of cytoplasmic proteins such as calpain and gelsolin. These proteins cut the actin cytoskel-
eton protein network, allowing membrane budding and removing capping proteins at the end
of the actin filaments [66–67]. A disruption in actin filaments and vimentin at the time of the
invasion of cells with trypomastigotes has been demonstrated [68–69] using drugs like cyto-
chalasin B and latrunculin, which affect the cytoskeletal structure and functions and, therefore,
the entrance of the parasite in non-phagocytic cells [32–33,70]. It has been mentioned that the
increase in intracellular Ca2+ leads to a rapid and transient reorganization of host-cell microfil-
aments, including the disassembly of the actin cytoskeleton, which is important for the entry
of T into the host cells [71–73]. Studying the gene-expression changes caused by microvesicles
of T. cruzi epimastigotes of the DM28c strain in mammalian host cells, Garcia Silva et al.
(2014) observed an induction of a broad response, including the modification of the host-cell
cytoskeleton and the extracellular matrix [74]. In fact, the regulation of actin cytoskeleton is
one of the pathways identified as being affected by EV treatment in the profile of transcriptome
changes [74]. Noting increased fluorescence in cells incubated with EVs in the presence of
Fluo-4AM, we suspected that these changes in the Ca2+ mobilization induced by EVs could
directly affect the actin cytoskeleton, as happens when the parasite begins to invade the host
cell. Our results showed a clear disruption of host-cell actin from 15 min after the incubation
with EVs, an effect that remains at 120 min but not 24 h after the treatment with EVs. Ferreira
et al. (2006) indicated that different strains of Mt of T. cruzi can invade host cells through both
actin cytoskeleton-dependent and independent routes, by engaging different surface molecules
for attachment while triggering different signal-transduction pathways [34]. For example,
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host-cell invasion by the strain CL Mt, mediated mainly by the surface molecule gp82, is asso-
ciated with F-actin disassembly whereas the G strain is gp35/50-mediated invasion by strain G
depends on target-cell actin cytoskeleton [34,75].
The analysis of the cell cycle events revealed how at 8 h after the addition of the EVs the per-
centage of cells in each of the cycle phases significantly differed when compared to control val-
ues, showing an arrest of the cell cycle in the G0/G1 phases. Previous observations regarding
the in vitro life cycle of T. cruzi in cultured cells demonstrated a low cell-division rate among
cells infected with the parasite [76–78]. In this regard, Ca2+ may be responsible for the cell
cycle changes, as they act as second messengers in the control of the cell cycle. Thus, Ca2+/cal-
modulin activate the complex CDK4/cyclin D1, which regulates the protein of Retinoblastoma
(pRb1), the main inhibitor of the DNA synthesis [79]. From our results, it is evident that the
phosphorylation of the protein Rb takes place from the first few min of the EVs/cell interac-
tion. Here, phosphorylated pRb increased rapidly, while in the cells without the treatment with
EVs no such change was detected (Fig 5B and 5C). However, at 60 min of treatment with EVs,
these increases in phosphorylation returned to normal levels. This apparently arrested synthe-
sis, preventing the cells from entering phase S of the cycle. Moreover, a series of “calcium sen-
sors” present in the cell cytoplasm, such as the stromal interaction molecule 1 (STIM1), is
involved in the progression of mitosis. Cells lacking this protein may arrest the cells in phases
G0/G1, as occurred in our experiments. This implies that this protein is required for the pro-
gression of the cells in the phase of DNA synthesis or phase S [80]. The arrest of cells in the
G0/G1 phases exerted by EVs of T. cruzi Pan4 was possibly caused by increased expression of
cyclin-dependent kinase inhibitor p21 and the subsequent decrease of phosphorylated protein
(pRb) [81]. The higher intracellular calcium levels were also involved in cell-cycle events. In
fact, the indirect role of high levels of calcium in cell arrest in these phases has been examined
by Wu et al. (2006) [82], who employed capsaicin and blocked the cell cycle in the previous
phase of DNA synthesis. This effect was reversed with BAPTA, an intracellular Ca
2+
chelator.
Together with the rises of intracellular calcium levels, and because of these high levels, these
researchers have recently questioned the role of actin networks nucleated by the complex
Arp2/3 in the signalling events necessary for the progression of the cell cycle in non-trans-
formed cells [82–83] and demonstrated that Arp2/3 is not able to act as a sensor for the start of
the phase S in the cell cycle per se, such as the actin filaments. Previous studies have shown
that the use of cytochalasin B at very low doses detains the cell cycle in phases G0/G1 as in our
experiments with EVs while the inhibitors that act in the polymerization of actin stopped the
cell cycle before the cytokinesis [84–86].
In conclusion, it has been shown that the incubation of cells with EVs of TcT of T. cruzi
Pan4 strain induce a number of changes in the host cells that include 1) a change in cell perme-
ability, and 2) higher intracellular levels of Ca2+ that can alter the dynamics of the actin cyto-
skeleton and arrest the cell cycle at G0/G1 prior to the DNA synthesis necessary to complete
mitosis. In the end, these changes induced by the EVs aid their invasion of host cells, augment
the percentage of cell parasitization, and possibly cause some characteristic manifestations of
Chagas disease.
Supporting information
S1 Fig. Evaluation of the isolation procedure of EVs of T. cruzi. TEM images show the vari-
ety of sizes of EVs of TcT of T. cruzi Pan4 strain (A). The presence of cruzipain, trans-sialidase
and MASPs (SP) in these EVs was also evaluated by Western blotting (B); a) detection of cruzi-
pain in EVs of tripomastigotes of T. cruzi Pan4 (1) and in a lysate of trypomastigotes of T.
cruzi Pan4 (2); b) detection of trans-sialidase (mAb 39) in a lysate of trypomastigotes of T.
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cruzi Pan4 (1) and in EVs of tripomastigotes of T. cruzi Pan4 (2); c) detection of MASPs (SP)
in EVs of tripomastigotes of T. cruzi Pan4. NTA (C) and DLS (D) of EVs of T. cruzi Pan 4
strain, DLS of EVs of Crithidia mellificae (E) and DLS of EVs of the 3T3 cell line (F) are also
included.
(TIF)
S2 Fig. Optimization of EV-cell incubation conditions and invasion assays. Vero cell parasit-
ization after the incubation with different doses of EVs of T. cruzi Pan4 was evaluated and the
maximum increase in this percentage was achieved when 0.50 μg/mL of EVs were employed
(A). The ED50 was calculated and employed in the incubation of the cells with EVs. These cells
were subsequently infected with trypomastigotes at different time points and the parasitization
percentages were calculated (B). Pictures a) and b) from this Figure show Vero cells incubated
with EVs prior to the infection with TcT of the Pan4 strain and stained with Giemsa. Picture c)
corresponds to the control cells infected with TcT without the previous treatment of cells with
EVs. Additionally, the percentages of parasitization of Vero cells incubated with T. cruzi EVs
submitted to thermal (C) and chemical treatments (D) were also calculated. The thermal treat-
ment appeared to “inactivate” the EVs, as no increase in the percentage of parasitization was
detected. In the case of the cells incubated with the chemically-treated EVs, the percentage of
parasitization was also lower compared to the percentage of the cells incubated with EVs with-
out treatment. Tukey test, p<0.0001 (���); Ns: non-significant differences.
(TIF)
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63. Pap E, Pállinger É, Pásztói M, Falus A. Highlights of a new type of intercellular communication: microve-
sicle-based information transfer. Inflamm Res. 2009; 58(1):1–8. https://doi.org/10.1007/s00011-008-
8210-7 PMID: 19132498
64. Savina A, Furlán M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mech-
anism in K562 cells. J Biol Chem. 2003; 278(22):20083–20090. https://doi.org/10.1074/jbc.
M301642200 PMID: 12639953
65. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-pro-
duced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal
survival. J Neurosci. 2010; 30(20):6838–6851. https://doi.org/10.1523/JNEUROSCI.5699-09.2010
PMID: 20484626
66. Gremm D, Wegner A. Gelsolin as a calcium-regulated actin filament-capping protein. Eur J Biochem.;
2000; 267(14):4339–4345. PMID: 10880956
67. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications.
Blood Rev. 2007; 21(3):157–171. https://doi.org/10.1016/j.blre.2006.09.001 PMID: 17118501
68. Low HP, Paulin JJ, Keith CH. Trypanosoma cruzi infection of BSC-1 fibroblast cells causes cytoskeletal
disruption and changes in intracellular calcium levels. 1992; 39(4):463–470. PMID: 1403981
69. Carvalho TM, Ferreira AG, Coimbra ES, Rosestolato CT, de Souza W. Distribution of cytoskeletal struc-
tures and organelles of the host cell during evolution of the intracellular parasitism by Trypanosoma
cruzi. J Submicrosc Cytol Pathol. 1999; 31(3):325–333. PMID: 10626001
70. Woolsey AM, Burleigh BA. Host cell actin polymerization is required for cellular retention of Trypano-
soma cruzi and early association with endosomal/lysosomal compartments. Cell Microbiol. 2004; 6
(9):829–838. https://doi.org/10.1111/j.1462-5822.2004.00405.x PMID: 15272864
71. Dorta ML, Ferreira AT, Oshiro MEM, Yoshida N. Ca2+ signal induced by Trypanosoma cruzi metacyclic
trypomastigote surface molecules implicated in mammalian cell invasion. Mol Biochem Parasitol. 1995;
73(1–2):285–289. PMID: 8577342
72. Rodrı́guez A, Samoff E, Rioult MG, Chung A, Andrews NW. Host cell invasion by trypanosomes requires
lysosomes and microtubule/kinesin-mediated transport. J Cell Biol. 1996; 134(2):349–362. PMID: 8707821
73. Martins RM, Alves RM, Macedo S, Yoshida N. Starvation and rapamycin differentially regulate host cell
lysosome exocytosis and invasion by Trypanosoma cruzi metacyclic forms. Cell Microbiol. 2011; 13
(7):943–954. https://doi.org/10.1111/j.1462-5822.2011.01590.x PMID: 21501360
74. Garcia Silva MR, Cura Das Neves RF, Cabrera Cabrera F, Sanguinetti J, Medeiros LC, Robello C, et al.
Extracellular vesicles shed by Trypanosoma cruzi are linked to small RNA pathways, life cycle regula-
tion, and susceptibility to infection of mammalian cells. Parasitol Res. 2014; 113(1):285–304. https://
doi.org/10.1007/s00436-013-3655-1 PMID: 24241124
75. Cortez M, Atayde V, Yoshida N. Host cell invasion mediated by Trypanosoma cruzi surface molecule
gp82 is associated with F-actin disassembly and is inhibited by enteroinvasive Escherichia coli.
Microbes Infect. 2006; 8(6):1502–1512. https://doi.org/10.1016/j.micinf.2006.01.007 PMID: 16697683
76. Meyer H, de Oliveira X. Observados sobre as divisoes mitoticas em células parasitadas. An Acad Bras
Cienc. 1942; 14:289–291.
77. Rubio M. Mitosis en células parasitadas por Trypanosoma cruzi. Estudio en animales de laboratorio.
Biol Santiago. 1956; 22:51–56.
78. Dvorak JA, Hyde TP. Trypanosoma cruzi: interaction with vertebrate cells in vitro. Individual interactions
at the cellular and subcellular levels. Exp Parasitol. 1973; 34(2):268–283. PMID: 4583055
79. Takuwa N, Zhou W, Kumada M, Takuwa Y. Ca(2+)-dependent stimulation of retinoblastoma gene prod-
uct phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J Biol Chem.
1991; 268: 138–145.
80. Sundivakkam PC, Freichel M, Singh V, Yuan JP, Vogel SM, Flockerzi V, et al. The Ca(2+) sensor stro-
mal interaction molecule 1 (STIM1) is necessary and sufficient for the store-operated Ca(2+) entry func-
tion of transient receptor potential canonical (TRPC) 1 and 4 channels in endothelial cells. Mol
Pharmacol. 2012; 81(4):510–526. https://doi.org/10.1124/mol.111.074658 PMID: 22210847
81. Guo RW, Wang H, Gao P, Li MQ, Zeng CY, Yu Y, et al. An essential role for stromal interaction mole-
cule 1 in neointima formation following arterial injury. Cardiovasc Res. 2009; 81(4):660–668. https://doi.
org/10.1093/cvr/cvn338 PMID: 19052075
82. Wu C, Asokan SB, Berginski ME, Haynes EM, Sharpless NE, Griffith JD, et al. Arp2/3 is critical for
lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis. Cell. 2012;
148(5):973–987. https://doi.org/10.1016/j.cell.2011.12.034 PMID: 22385962
EVs of T. cruzi trypomastigotes: Physiological changes in non-parasitized cells
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007163 February 21, 2019 25 / 26
83. Dang I, Gautreau A. Evidence for a cell cycle checkpoint that senses branched actin in the lamellipo-
dium. BioEssays. 2012; 34(12):1021–1024. https://doi.org/10.1002/bies.201200119 PMID: 23080513
84. Maness PF, Walsh RC. Dihydrocytochalasin B disorganizes actin cytoarchitecture and inhibits initiation
of DNA synthesis in 3T3 cells. Cell. 1982; 30(1):253–262. PMID: 6215122
85. Rubtsova S, Kondratov R, Kopnin P, Chumakov P, Kopnin B, Vasiliev J. Disruption of actin microfila-
ments by cytochalasin D leads to activation of p53. FEBS Lett. 1998; 430(3):353–357. PMID: 9688570
86. Lohez OD, Reynaud C, Borel F, Andreassen PR, Margolis RL. Arrest of mammalian fibroblasts in G1 in
response to actin inhibition is dependent on retinoblastoma pocket proteins but not on p53. J Cell Biol.
2003; 161(1):67–77. https://doi.org/10.1083/jcb.200208140 PMID: 12682090
EVs of T. cruzi trypomastigotes: Physiological changes in non-parasitized cells
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007163 February 21, 2019 26 / 26
